178 related articles for article (PubMed ID: 27998070)
21. Lytic peptide-grafted beta-cyclodextrin polymer based nano-scaled drug delivery system with enhanced camptothecin anti-cancer efficacy.
Zhan H; Zhao H; Muhammad N; Li T; Liu Y; Wang J
Nanotechnology; 2020 Feb; 31(7):075101. PubMed ID: 31665708
[TBL] [Abstract][Full Text] [Related]
22. In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer.
Gigliotti CL; Minelli R; Cavalli R; Occhipinti S; Barrera G; Pizzimenti S; Cappellano G; Boggio E; Conti L; Fantozzi R; Giovarelli M; Trotta F; Dianzani U; Dianzani C
J Biomed Nanotechnol; 2016 Jan; 12(1):114-27. PubMed ID: 27301177
[TBL] [Abstract][Full Text] [Related]
23. Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent.
Kang J; Kumar V; Yang D; Chowdhury PR; Hohl RJ
Eur J Pharm Sci; 2002 Mar; 15(2):163-70. PubMed ID: 11849913
[TBL] [Abstract][Full Text] [Related]
24. Supramolecular Polymer-Based Nanomedicine: High Therapeutic Performance and Negligible Long-Term Immunotoxicity.
Yu G; Zhao X; Zhou J; Mao Z; Huang X; Wang Z; Hua B; Liu Y; Zhang F; He Z; Jacobson O; Gao C; Wang W; Yu C; Zhu X; Huang F; Chen X
J Am Chem Soc; 2018 Jun; 140(25):8005-8019. PubMed ID: 29874067
[TBL] [Abstract][Full Text] [Related]
25. Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.
Svenson S; Wolfgang M; Hwang J; Ryan J; Eliasof S
J Control Release; 2011 Jul; 153(1):49-55. PubMed ID: 21406204
[TBL] [Abstract][Full Text] [Related]
26. Testosterone- and vitamin-grafted cellulose ethers for sustained release of camptothecin.
Quiñones JP; Mardare CC; Hassel AW; Brüggemann O
Carbohydr Polym; 2019 Feb; 206():641-652. PubMed ID: 30553368
[TBL] [Abstract][Full Text] [Related]
27. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
28. Dual targeting system by supramolecular complex of folate-conjugated methyl-β-cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer.
Elamin KM; Motoyama K; Higashi T; Yamashita Y; Tokuda A; Arima H
Int J Biol Macromol; 2018 Jul; 113():386-394. PubMed ID: 29486262
[TBL] [Abstract][Full Text] [Related]
29. Polyanionic Cyclodextrin Induced Supramolecular Nanoparticle.
Sun HL; Zhang YM; Chen Y; Liu Y
Sci Rep; 2016 Dec; 6(1):27. PubMed ID: 28442707
[TBL] [Abstract][Full Text] [Related]
30. Transformative Nanomedicine of an Amphiphilic Camptothecin Prodrug for Long Circulation and High Tumor Uptake in Cancer Therapy.
Zhang F; Zhu G; Jacobson O; Liu Y; Chen K; Yu G; Ni Q; Fan J; Yang Z; Xu F; Fu X; Wang Z; Ma Y; Niu G; Zhao X; Chen X
ACS Nano; 2017 Sep; 11(9):8838-8848. PubMed ID: 28858467
[TBL] [Abstract][Full Text] [Related]
31. Mechanistic Insight into Receptor-Mediated Delivery of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantamethamidyl Host:Guest pDNA Nanoparticles to CD44(+) Cells.
Badwaik V; Liu L; Gunasekera D; Kulkarni A; Thompson DH
Mol Pharm; 2016 Mar; 13(3):1176-84. PubMed ID: 26900622
[TBL] [Abstract][Full Text] [Related]
32. Supramolecular assembly and antitumor activity of multiwalled carbon nanotube-camptothecin complexes.
Tian Z; Yin M; Ma H; Zhu L; Shen H; Jia N
J Nanosci Nanotechnol; 2011 Feb; 11(2):953-8. PubMed ID: 21456124
[TBL] [Abstract][Full Text] [Related]
33. pH-sensitive drug loading/releasing in amphiphilic copolymer PAE-PEG: integrating molecular dynamics and dissipative particle dynamics simulations.
Luo Z; Jiang J
J Control Release; 2012 Aug; 162(1):185-93. PubMed ID: 22743107
[TBL] [Abstract][Full Text] [Related]
34. Supramolecular assembly of cyclodextrin-based nanoparticles on solid surfaces for gene delivery.
Park IK; von Recum HA; Jiang S; Pun SH
Langmuir; 2006 Sep; 22(20):8478-84. PubMed ID: 16981766
[TBL] [Abstract][Full Text] [Related]
35. Preparation, formula optimization and antitumor actions of mannitol coupling camptothecin nanoparticles.
Wang Z; Li Q; Zhao X; Sun B; Zhu Q; Gao W; Hua C
Int J Pharm; 2014 Apr; 465(1-2):360-7. PubMed ID: 24530520
[TBL] [Abstract][Full Text] [Related]
36. Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe
Krishnan P; Rajan M; Kumari S; Sakinah S; Priya SP; Amira F; Danjuma L; Pooi Ling M; Fakurazi S; Arulselvan P; Higuchi A; Arumugam R; Alarfaj AA; Munusamy MA; Hamat RA; Benelli G; Murugan K; Kumar SS
Sci Rep; 2017 Sep; 7(1):10962. PubMed ID: 28887536
[TBL] [Abstract][Full Text] [Related]
37. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
38. A novel composite hydrogel based on chitosan and inorganic phosphate for local drug delivery of camptothecin nanocolloids.
Li X; Kong X; Zhang J; Wang Y; Wang Y; Shi S; Guo G; Luo F; Zhao X; Wei Y; Qian Z
J Pharm Sci; 2011 Jan; 100(1):232-41. PubMed ID: 20533555
[TBL] [Abstract][Full Text] [Related]
39. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22.
Yang A; Liu Z; Yan B; Zhou M; Xiong X
Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540
[TBL] [Abstract][Full Text] [Related]
40. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
